SBIR Phase II: Cryogenic probe development and testing for post-lumpectomy margin ablation — NSF Award to SENOGUARD, INC. (CA, $99
The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project is a novel minimally invasive thermal therapy for improving post surgical lumpectomy outcomes. In the US, 300,000 new breast cancer cancer diagnoses occur each year with nearly half, or 150,000, undergoing surgica
| Award title | SBIR Phase II: Cryogenic probe development and testing for post-lumpectomy margin ablation |
|---|---|
| Award ID | 2404500 |
| Awardee | SENOGUARD, INC. |
| City | SEAL BEACH |
| State | CA |
| Amount obligated | $999,545 |
| Principal investigator | Dan Wittenberger |
| Program | SBIR Phase II |
| Start date | 12/01/2024 |
| Abstract | The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project is a novel minimally invasive thermal therapy for improving post surgical lumpectomy outcomes. In the US, 300,000 new breast cancer cancer diagnoses occur each year with nearly half, or 150,000, undergoing surgical excision of the tumor. These patients are also required to undergo subsequent radiation therapy to decrease the risks of recurrence. The follow on treatments require multiple fol |
| Source | NSF Awards |
$799/mo
Try NSFGrants →